The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks start week in subdued state

Mon, 27th Nov 2023 16:12

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

The FTSE 100 closed down 0.37% at 7,460.70 points, while the FTSE 250 showed a slight decline of 0.11%, settling at 18,438.55 points.

The dip in London stocks came on the back of renewed apprehensions about China's economic outlook.

During October, China experienced a deceleration in its industrial profit growth, triggering speculations that the government may need to implement additional stimulus measures to sustain economic momentum and prevent a downturn.

In currency markets, sterling was last up 0.02% on the dollar to trade at $1.2605, while it managed gains of 0.04%, changing hands at €1.1530.

"It's been a subdued start to the week for markets in Europe, following on from a weak Asia session, with a predominantly softish tone all around, as investors indulge in mild profit-taking after the strong gains of the last couple of weeks," said CMC Markets chief market analyst Michael Hewson.

"On the plus side, online estate agent Rightmove shares are among the best performers today, rising to give-week highs after upgrading its full-year outlook for revenue growth and average revenue per advertiser."

Retail sales decline slows in November

In economic news, fresh survey results from the Confederation of British Industry (CBI) showed that the decline in UK retail sales showed signs of easing in November, although a sombre outlook loomed over the upcoming Christmas season.

The CBI's monthly retail sales balance saw improvement, rising from -36 in October to -11 in November.

That still marked the seventh consecutive monthly decrease, with sales growth expected to remain marginally negative next month.

Despite retailers expressing disappointment over sales levels for this time of year, a modest recovery in sentiment was noted in November.

Businesses appeared cautiously optimistic, foreseeing a slight improvement in their business situations over the next three months.

"Retail sales have languished in negative territory for much of 2023, reflecting the impact of strained household finances on the sector's fortunes," said CBI principal economist Martin Sartorius.

"Though sentiment has picked up slightly, firms do not feel that a revival in activity is imminent.

"Given the weakness in trading conditions, it's little surprise that firms are scaling back on their investment ambitions."

Sartorius added that retailers had hoped the Chancellor's Autumn Statement would offer a reprieve from next year's hike in business rates.

"While prioritising relief for small-to-medium enterprises and key sectors is understandable, many retailers are being left to contend with another increase in costs at a time when they are least able to afford them."

Entain and AstraZeneca fall on broker notes, Rightmove rises

On London's equity markets, Entain was down 1.73% after a downgrade from Goldman Sachs.

The investment bank shifted its rating from 'buy' to 'sell,' citing a belief that fundamental improvements may take longer to materialise.

Goldman Sachs revised its earnings estimates down by approximately 30% for Entain's 2024 and 2025 financial years.

Pharmaceutical giant AstraZeneca was off 1.73% after a broker note from Jefferies, which lowered its price target on the shares from 13,000p to 12,500p.

On the upside, precious metals miner Fresnillo jumped 4.39% amid a rally in gold prices.

Rightmove added 4.6% after raising its full-year revenue per advertiser forecast.

The real estate marketing platform attributed the positive outlook to solid demand for its products since its last report, with the new average revenue per advertiser (ARPA) growth expectations now ranging from £112 to £116, up from the previous guidance of £103 to £105.

West End landlord Shaftesbury Capital was ahead 4.55% after the company celebrated a "strong" start to Christmas trading, reporting high footfall and sales tracking above the previous year.

Sales were notably up 12% compared to 2022 and 16% above 2019.

Johnson Matthey rose 3.14% following an upgrade from 'underperform' to 'buy' by Bank of America Merrill Lynch.

The upgrade was based on the belief that Johnson Matthey could extract more value from its clean air franchise through cost-cutting efforts and generate new revenue streams in its catalyst tech business.

Aviva also made headlines as it agreed to acquire Optiom from Novacap and other minority shareholders for approximately £100m.

Optiom, a managing general agent, specialises in providing vehicle replacement insurance in Canada and offers flexible payment options to its customers.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,460.70 -0.37%

FTSE 250 (MCX) 18,438.55 -0.11%

techMARK (TASX) 4,093.59 -0.67%

FTSE 100 - Risers

Rightmove (RMV) 533.60p 4.79%

Fresnillo (FRES) 551.40p 4.31%

Admiral Group (ADM) 2,709.00p 1.69%

RS Group (RS1) 767.40p 1.51%

Sainsbury (J) (SBRY) 276.20p 1.51%

Endeavour Mining (EDV) 1,760.00p 1.50%

Frasers Group (FRAS) 880.50p 1.44%

Sage Group (SGE) 1,119.00p 1.36%

Auto Trader Group (AUTO) 709.80p 1.31%

Barratt Developments (BDEV) 501.40p 1.29%

FTSE 100 - Fallers

St James's Place (STJ) 645.80p -2.42%

AstraZeneca (AZN) 9,976.00p -2.00%

BAE Systems (BA.) 1,049.50p -1.73%

International Consolidated Airlines Group SA (CDI) (IAG) 150.85p -1.60%

Flutter Entertainment (CDI) (FLTR) 12,420.00p -1.58%

Burberry Group (BRBY) 1,504.00p -1.57%

Prudential (PRU) 908.80p -1.39%

Rentokil Initial (RTO) 448.70p -1.38%

Smurfit Kappa Group (CDI) (SKG) 2,706.00p -1.02%

NATWEST GROUP (NWG) 203.90p -1.02%

FTSE 250 - Risers

Shaftesbury Capital (SHC) 120.70p 3.69%

Syncona Limited NPV (SYNC) 123.80p 3.17%

Johnson Matthey (JMAT) 1,590.50p 2.88%

Tritax Eurobox (GBP) (EBOX) 56.70p 2.53%

HICL Infrastructure (HICL) 136.80p 2.40%

Centamin (DI) (CEY) 92.25p 2.33%

Dr. Martens (DOCS) 111.00p 2.30%

Carnival (CCL) 1,023.00p 2.30%

Mitie Group (MTO) 99.30p 2.16%

Bellway (BWY) 2,436.00p 2.10%

FTSE 250 - Fallers

Ceres Power Holdings (CWR) 187.90p -3.84%

Indivior (INDV) 1,262.00p -3.52%

Jupiter Fund Management (JUP) 81.50p -3.15%

Hipgnosis Songs Fund Limited NPV (SONG) 69.00p -3.09%

888 Holdings (DI) (888) 77.80p -3.05%

Ithaca Energy (ITH) 154.40p -3.02%

Chemring Group (CHG) 310.00p -2.82%

Coats Group (COA) 67.50p -2.74%

FDM Group (Holdings) (FDM) 399.00p -2.56%

Apax Global Alpha Limited (APAX) 150.20p -2.47%

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.